Arena Pharmaceuticals

Markets Marginally Lower Ahead Of Earnings Season

Earnings Expectations For The Week Of May 12: Wal-Mart, Deere, Cisco And More

#PreMarket Primer: Friday, February 14: A Turnaround

Earnings Expectations For The Week Of May 12: Wal-Mart, Deere, Cisco And More

#PreMarket Primer: Friday, February 14: A Turnaround

Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony

Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony

Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)

Arena Pharmaceuticals Recent News

Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)

Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)

Short Interest in Vertex Rises, in Biogen Idec Falls

Short Interest in Vertex Rises, in Celgene Falls

Short Sellers Move into Celgene, Regeneron

Short Sellers Move Out of Amgen, Celgene, Pharmacyclics

Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences

Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)

Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)

Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)

Short Sellers Shy Away from Biotech Firms

Short Interest in Biotech Firms on the Rise

Dendreon, Pharmacyclics and Other Biotech Takeover Targets

Oppenheimer Reviews Arena Pharmaceuticals at the Quarter

Oppenheimer Raises EPS Estimate From $0.58 To $0.69 On ARNA

Hapoaliom Views Arena's Lorcaserin As Unapprovable

Arena Waiting On FDA Approval Of Lorcaserin